About Us News & Events Investors Careers
Search
Products Solutions Technologies Disease States Contact Us

Press Releases

2008


Nov 17, 2008   Nanogen Reports 2008 Third Quarter Financial Results
 
Nov 14, 2008   Nanogen to Host Third Quarter Conference Call November 17, 2008
 
Nov 7, 2008   Nanogen Partners with Menarini to Capture European Molecular Diagnostics Market
 
Oct 23, 2008   Nanogen Extends Celera License Agreement for Additional IVD Products
 
Oct 15, 2008   Nanogen Receives Award for 5-Year Growth Record Second Year in Deloitte's Technology Fast 50
 
Aug 15, 2008   Accelerator Corporation Creates Ninth Biotech Company - Takes Nanogen License to Create Novel Therapeutics
 
Aug 14, 2008   Nanogen Announces Combination with The Elitech Group
 
Aug 13, 2008   Nanogen Reports 2008 Second Quarter Financial Results
 
Aug 12, 2008   Nanogen to Host Second Quarter Conference Call August 14, 2008
 
Aug 5, 2008   HX Diagnostics and Nanogen Expand Collaboration
 
Jun 5, 2008   Nanogen Awarded New CDC Contract to Develop Molecular Diagnostic Test for Influenza and Avian Flu
 
May 23, 2008   Nanogen Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
 
May 22, 2008   Nanogen Announces Consolidation of Point of Care Manufacturing Operations
 
May 12, 2008   Nanogen Reports 2008 First Quarter Financial Results
 
Apr 2, 2008   Nanogen and Thermo Fisher Scientific Partner to Provide Molecular Biology Products to Research Market
 
Mar 31, 2008   DRI Capital Inc. Acquires Royalties from Nanogen Inc. for US $10 Million
 
Mar 14, 2008   Nanogen Enters into Agreement to Restructure its Senior Convertible Notes
 
Mar 13, 2008   Nanogen Reports 2007 Preliminary Fourth Quarter and Full Year Financial Results
 
Mar 11, 2008   Nanogen to Host Fourth Quarter Conference Call March 13, 2008
 
Feb 13, 2008   Nanogen Receives Final Stockholder Approval on Debt Financing
 
Feb 1, 2008   Nanogen Receives Stockholder Approval on Two of Three Proposals and Adjourns Special Meeting to February 11, 2008
 
Jan 31, 2008   Nanogen Patent Portfolio in Realtime PCR Strengthened
 

2007


Dec 14, 2007   Nanogen Announces Retirement of CFO; Appoints Successor
 
Dec 11, 2007   Rosetta Genomics Selects PCR as Platform for its MicroRNA-Based Diagnostics to be Launched in 2008
 
Dec 10, 2007   Nanogen, Inc. Files Preliminary Proxy Statement
 
Dec 10, 2007   Nanogen Reaches Milestone in CDC Influenza Project
 
Nov 28, 2007   Nanogen Strengthens Cardiac Biomarker Patent Position as US Patent Office Reissues Patent for Diagnosis of Chronic Congestive Heart Failure
 
Nov 12, 2007   Nanogen to Close Array Business - Will Focus on Two High Growth Product Lines
 
Nov 12, 2007   Nanogen Reports Third Quarter Financials
 
Nov 9, 2007   Nanogen to Host Third Quarter Conference Call on November 12, 2007
 
Oct 1, 2007   Nanogen Extends IP Portfolio with Nucleic Acid Detection and Genotyping Technology Patents
 
Sep 17, 2007   Nanogen to Focus on High Growth Clinical Diagnostics Markets with Real Time and Point of Care Products; Undertakes Evaluation of Strategic Alternatives for Microarray Business
 
Aug 27, 2007   Nanogen Announces $20 Million Financing Transaction
 
Aug 8, 2007   Nanogen Reports 2007 Second Quarter Financial Results
 
Aug 6, 2007   Nanogen to Host Second Quarter Conference Call on August 8, 2007
 
Jul 17, 2007   Nanogen Begins Shipment of Congestive Heart Failure Product
 
Jul 11, 2007   Nanogen Gains Access to Schizophrenia Markers
 
Jun 12, 2007   Nanogen Announces Collaboration with Canadian Agencies to Develop Veterinary and Bioterror Diagnostics
 
May 9, 2007   Nanogen Reports 2007 First Quarter Financial Results
 
May 2, 2007   Nanogen to Host First Quarter Conference Call and Webcast on May 9, 2007
 
Apr 17, 2007   Nanogen Submits 510(K) for Cystic Fibrosis Genetic Assay and NanoChip® 400 System
 
Apr 4, 2007   Nanogen Obtains GSA Contract for NanoChip® 400 Platform
 
Feb 28, 2007   Nanogen Awarded Patents for Biomarkers Associated with Diabetes, Alzheimers Disease
 
Feb 20, 2007   Nanogen Reports 2006 Fourth Quarter and Year-End Financial Results
 
Feb 19, 2007   Nanogen to Host Fourth Quarter Conference Call and Webcast on February 20, 2007
 
Jan 31, 2007   Heller Presents Nanofabrication Advances Using Nanogen Technology at Lab Automation Conference
 

2006


Dec 6, 2006   Nanogen Releases Pharmacogenetics Research Reagents for CYP2C9 and VKORC1 Analysis
 
Dec 4, 2006   Nanogen Wins CDC Contract to Develop Avian Flu Diagnostic
 
Nov 1, 2006   Nanogen Reports 2006 Third Quarter Financial Results
 
Oct 31, 2006   Heiner Dreismann, former Roche Executive, Joins Nanogen Board of Directors
 
Oct 30, 2006   Nanogen Awarded Additional Patents for Diabetes, Alzheimers Disease Biomarkers
 
Oct 30, 2006   Nanogen to Host Third Quarter Conference Call and Webcast on November 1, 2006
 
Oct 5, 2006   Nanogen Announces Consolidation and Cost Reduction Actions
 
Oct 4, 2006   Drug Royalty Corporation Inc. Acquires Royalties from Nanogen Inc. for $20 Million
 
Sep 6, 2006   New Patent Expands Nanogen's Core Nanotechnology Position
 
Aug 24, 2006   Nanogen Earns Patents for use of Biomarkers Related to Diabetes and Alzheimers Disease
 
Aug 23, 2006   Nanogen Expands Point-of-Care Product Line to Include Drugs of Abuse Tests
 
Aug 9, 2006   Fisher Healthcare to Distribute Nanogen Real-Time PCR Products to Clinical Laboratories
 
Aug 9, 2006   Nanogen Reports 2006 Second Quarter Financial Results
 
Aug 7, 2006   Nanogen to Host Second Quarter Conference Call and Webcast on August 9, 2006
 
Aug 3, 2006   Nanogen and Fisher Scientific Expand Molecular Diagnostics R&D Collaboration Agreement
 
Jul 13, 2006   Nanogen Releases New Real-Time PCR Reagents
 
Jun 15, 2006   Nanogen Releases Enterovirus Reagent Employing Newly Patented Hybridization Technology
 
May 15, 2006   Nanogen Announces Type II Diabetes Research Collaboration
 
May 11, 2006   Nanogen Reports 2006 First Quarter Financial Results
 
May 10, 2006   Nanogen Receives $25 Million Equity Financing Commitment
 
May 8, 2006   Nanogen to Release First Quarter Financial Results and Host Webcast on May 11, 2006
 
May 2, 2006   DrugMEt Pharmacogentics Product Achieves CE Mark for IVD Use
 
Apr 25, 2006   Nanogen Expands Real-Time Portfolio with Release of Product for the Detection of Epstein-Barr Virus (EBV)
 
Apr 20, 2006   Nanogen to Acquire European Molecular Diagnostics Company Amplimedical
 
Apr 17, 2006   Nanogen Earns Two Patents for Therapeutic and Diagnostic Use of Biomarkers
 
Mar 29, 2006   Nanogen Receives 510(K) Clearance for Congestive Heart Failure NT-proBNP Test
 
Mar 23, 2006   Nanogen Launches Cystic Fibrosis Analyte Specific Reagents
 
Mar 16, 2006   Nanogen Receives $15 Million Strategic Investment from Fisher
 
Mar 13, 2006   Nanogen Issues Patent for Integrated Sample Preparation and Detection Device
 
Feb 7, 2006   Nanogen Closes Acquisition of Point-of-Care Cardiac Diagnostic Test Business from Spectral Diagnostics
 

2005


Dec 22, 2005   Nanogen Expands Patent Portfolio in Genetic Analysis Technologies
 
Dec 20, 2005   Nanogen and Spectral Announce Rapid Cardiac Diagnostic Test Agreement
 
Dec 13, 2005   Nanogen Releases Two Products for the Detection of Respiratory Viral Pathogens
 
Nov 17, 2005   Nanogen Issued Patent for Technology Enabling Assay Development to Detect Difficult Nucleic Acid Sequences
 
Nov 8, 2005   Nanogen issued Patent for Key Component of Nanochip Electronic Microarray
 
Nov 2, 2005   Nanogen Reports 2005 Third Quarter Financial Results
 
Nov 1, 2005   Nanogen Point-of-Care Diagnostics Division Earns ISO Certification
 
Oct 27, 2005   Nanogen to Release Third Quarter Financial Results and Host Webcast on Wednesday, November 2, 2005
 
Oct 19, 2005   Nanogen Begins Shipments of NanoChip 400 Systems
 
Oct 11, 2005   Nanogen Announces Patent for Fluorescent Detection of Nucleic Acid Targets
 
Sep 28, 2005   Nanogen Announces $20 Million Common Stock Sale
 
Sep 26, 2005   Nanogen Issued Patent for Kinase Screening Technology
 
Aug 2, 2005   Nanogen Reports 2005 Second Quarter Financial Results
 
Aug 2, 2005   Nanogen Reports 2005 Second Quarter Financial Results
 
Aug 1, 2005   Nanogen Awarded $2.5 Million Grant for Development of Diagnostics for Sepsis and Pneumonia
 
Jul 27, 2005   Nanogen to Release Second Quarter Financial Results and Host Webcast on Tuesday, August 2, 2005
 
Jul 26, 2005   Nanogen Gains Access to Diagnostic Markers Through Investment in Jurilab
 
Jul 7, 2005   Nanogen Issued Patent for Method of Monitoring PCR Using Fluorescent Energy Transfer